Ovarian cancer
Ovarian cancer forms in the ovary. Cancer often progresses unnoticed and is only diagnosed when the disease has spread to the pelvis and abdomen. However at this late stage the treatment of ovarian cancer becomes much more difficult. If diagnosed at an early stage of the disease (when the cancer has only spread to the ovary), the chances of the patient recovering and managing the condition effectively are much higher.
Ovarian cancer is usually treated with surgery and chemotherapy.
During ovarian cancer, abnormal cells in the ovary multiply uncontrollably, resulting in a tumor. Without timely treatment, cancer can spread to other parts of the body and is called metastatic ovarian cancer.
Ovarian cancer is asymptomatic at an early stage, although rarely does the body warn you of certain signs.
Some women are born with an increased risk of developing ovarian cancer. This risk can be diagnosed by genetic research.
Ovarian cancer and genetic analysis
Genetic research is often of interest to women whose family members have been tested for BRCA1 and BRCA2 mutated genes. The BRCA1 and BRCA2 genes are linked to ovarian and breast cancer.
The test is also recommended in cases where a blood relative has been diagnosed with ovarian cancer or breast cancer has been diagnosed before the age of 50 years.
When a test confirms that you are at risk for developing ovarian cancer, your doctor will develop certain methods.
As a result of the analysis, the oncologist assesses the level of risk and makes an appropriate plan.
You may need:
- Surgical procedure when the ovaries and fallopian tubes are excised;
- Oral contraceptives may be prescribed to reduce the risk;
- Regular and intensive screening with ovarian ultrasound. The aim of this study is to detect any pathology and monitor the level of CA125 marker in the blood;
- Take measures to maintain childbearing.
Oncologists explain that the incidence of ovarian cancer increases if a person's mother, and either daughter was ill, or is now suffering from cancer. The more relatives with ovarian cancer, the higher the risk. The risk of ovarian cancer is high even if relatives from the father have the disease.
A family history of breast cancer and colorectal cancer should also be considered.
What do you need to know about the BRCA1 and BRCA2 genes?
Under normal circumstances, the BRCA1 and BRCA2 genes protect the body against a specific type of cancer, although in clinical cases where mutations in these genes occur, BRCA1 and BRCA2 cease to function properly. If a person inherits these mutations they are at risk for developing breast, ovarian and other cancers.
For what purpose is genetic analysis prescribed?
Genetic testing can detect mutations in the BRCA1 and BRCA2 genes.
The study also identifies other mutated genes involved in the development of ovarian cancer.
According to statistics, one in five women with ovarian cancer tests are positive, meaning that the body inherited a gene that underwent a mutation.
Response to the analysis:
- Positive. A positive test means you have mutated BRCA1 and BRCA2 genes and are at a higher risk of developing ovarian or breast cancer than others. However, a positive answer does not necessarily mean that you will develop cancer;
- Negative. A negative result indicates that the laboratory test could not find the BRCA gene in your body that would undergo the mutation. The test result is really negative if you did not find in your body a specific mutated BRCA gene, which has already been identified in the body of a relative;
- Doubtful, vague answer. We come to this conclusion when we encounter genetic variation in research that may or may not be associated with cancer risk. More research is needed.
What does I-Lab offer?
A subsidiary of Health and Tourism International Center and an official partner of the Turkish network of clinics "Acibadem" in Georgia, I-Lab Laboratory offers genetic testing to determine if you are a carrier of a mutated gene.
A safe and comfortable environment awaits you in the ultra-modern laboratory.
You can perform the analysis at your desired time.
Please note that pre-registration is required.
For detailed information, please contact:
Tel: (+995) 595380038;
WhatsApp: (+995) 595380038;
Viber: (+995) 595380038;
Telegram: (+995) 595380038;
Skype: (+995) 595380038;
Facebook: Health Tourism Int. Center
Mail: ilabgeo@gmail.com